Oxford University Claims that the Vaccine Test Against Corona is Extremely Safe:
The University of Oxford has developed a vaccine against coronavirus in collaboration with drug manufacturer AstraZeneca. The vaccine is claimed to have developed strong immunity against the coronavirus. In a study published in the Australian medical journal The Lancet, an Oxford University trial found the vaccine to be extremely safe.
One thousand 77 adults were included in the test. Within two months of vaccination, the immunity of the cells was found to be high in the volunteers.
The British government has already agreed to buy about 100 million of the vaccine. The vaccine has been developed by genetic engineering of the flu virus in chimpanzees. But Prime Minister Boris Johnson said it was too early to say whether the vaccine would be successful.
"We are not sure, we have not been able to get there, we still need a trial," he said. But he said it was an important step in the right direction.
The researchers also vaccinated ten volunteers for the second time to test their immune systems. "The vaccine is safe, with some other side effects, but strong immunity has been identified in both infections." - Preliminary results show.
"We're hopeful that this immune system will recognize the virus, so long-term vaccinations will help protect against the virus," said Andrew Pollard, lead author of the study and professor at Oxford University.
Research has shown that participants in early human trials produced antibodies and white blood cells to fight the virus.
Pollard said his team would still study the effectiveness of the vaccine in maintaining a long-term immune system against SARS-COV-2 infection. But it is not the only treatment that has shown effective results.
Major Success:
A British company is also looking for another way to develop immunity. According to the research, the preliminary results of the development of interferon-beta protein have shown that those infected with Covid-19 do not need ICU. Synergy, a pharmaceutical company, has helped 101 Kovid-19 infected people fight against SNG001 by combining naturally occurring antiviral proteins in the body.
The study found that 79 percent of patients who died without a ventilator were cured.
Welcome by the World Health Organization:
The World Health Organization has welcomed Oxford University's progress in vaccine development. The WHO on Monday welcomed Oxford University's progress and suggested that vaccine trials be carried out on a large scale worldwide.
WHO Executive Director Dr. Mike Ryan said: "The good news is that we have 23 vaccine clinical trials in development and today we have data on the first phase of a single vaccine."
He made the remarks in an article published in the Lancet Medical Journal on the World Health Organization's webinar.
"We welcome the results from Oxford University and would like to congratulate the research participants at the university, AstraZeneca and the Oxford Vaccine Group," he said. He said that there is still a long way to go while achieving positive results.
According to Johns Hopkins University in the United States, about 14.53 million people have been infected with COVID-19 as of Tuesday morning. About six lakh seven thousand people have died and 8.2 million infected have been cured.
